Director Christoph Ziegler Acquires 30,000 Veraxa Biotech Shares at Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
Director Christoph Samuel Ziegler recently purchased 30,000 ordinary shares of Veraxa Biotech AG (NASDAQ:VRXA) at Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.
Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
Director Christoph Samuel Ziegler recently purchased 30,000 ordinary shares of Veraxa Biotech AG (NASDAQ:VRXA) at Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context